Kononov, S.; Azarova, I.; Klyosova, E.; Bykanova, M.; Churnosov, M.; Solodilova, M.; Polonikov, A.
Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease. Genes 2023, 14, 1259.
https://doi.org/10.3390/genes14061259
AMA Style
Kononov S, Azarova I, Klyosova E, Bykanova M, Churnosov M, Solodilova M, Polonikov A.
Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease. Genes. 2023; 14(6):1259.
https://doi.org/10.3390/genes14061259
Chicago/Turabian Style
Kononov, Stanislav, Iuliia Azarova, Elena Klyosova, Marina Bykanova, Mikhail Churnosov, Maria Solodilova, and Alexey Polonikov.
2023. "Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease" Genes 14, no. 6: 1259.
https://doi.org/10.3390/genes14061259
APA Style
Kononov, S., Azarova, I., Klyosova, E., Bykanova, M., Churnosov, M., Solodilova, M., & Polonikov, A.
(2023). Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease. Genes, 14(6), 1259.
https://doi.org/10.3390/genes14061259